Follow-up to the ECVAM prevalidation study on in vitro tests for acute skin irritation. The European Centre for the Validation of Alternative Methods Skin Irritation Task Force report 2
2002
(2002) ATLA 30, 109-129 | ECVAM, Institute for Health & Consumer Protection, European Commission Joint Research Centre, 21020 Ispra (VA), Italy
Direct role of human dermal fibroblasts and indirect participation of epidermal keratinocytes in MMP-1 production after UV-B irradiation
2002
Arch Dermatol Res 2002 Jan ;293 (11):576-83 | L'OREAL, Advanced Research Laboratories, Centre Charles Zviak, Clichy, France. [email protected]
Functional expression of AQP3 in human skin epidermis and reconstructed epidermis
2002
J Invest Dermatol 2002 Apr ;118 (4):678-85 | Service de Biologie Cellulaire, CEA/Saclay, Gif-sur-Yvette, France.
Currently available in vitro methods used in the regulatory toxicology
2002
Toxicol Lett 2002 Feb 28 ;127 (1-3):127-34 | National Centre for Documentation and Evaluation of Alternative Methods to Animal Experiments (ZEBET), Federal Institute for Health Protection of Consumers and Veterinary Medicine (BgVV), Diedersdorfer Weg 1, D-12277 Berlin, Germany. [email protected]
The use and interpretation of in vitro data in regulatory toxicology: cosmetics, toiletries and household products
2002
Toxicol Lett 2002 Feb 28 ;127 (1-3):177-82 | Health and Safety Executive, Magdalen House, Stanley Precinct, Bootle, Merseyside L20 3QZ, UK. [email protected]
Effect of skin barrier competence on SLS and water-induced IL-1alpha expression
2002
Exp Dermatol 2002 Jun ;11 (3):217-23 | Department of Dermatology, Leiden University Medical Centre, The Netherlands. [email protected]
Effect of fibroblasts on epidermal regeneration
2002
Br J Dermatol 2002 Aug ;147 (2):230-43 | Department of Dermatology, Leiden University Medical Centre, Sylvius Laboratory, PO Box 9503, 2300 RA Leiden, The Netherlands.
Crucial role of fibroblasts in regulating epidermal morphogenesis
2002
Cell Tissue Res 2002 Nov ;310 (2):189-99 | Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands.
Fibroblasts and ascorbate regulate epidermalization in reconstructed human epidermis
2002
J Dermatol Sci 2002 Dec ;30 (3):215-23 | Department of Plastic and Reconstructive Surgery, Seoul National University, Seoul, South Korea.
Refinement of the Episkin protocol for the assessment of acute skin irritation of chemicals: follow-up to the ECVAM prevalidation study
2002
Toxicol In Vitro 2002 Dec ;16 (6):765-70 | L'Oreal Recherche, Aulnay sous Bois, France. [email protected]
Skin constructs for replacement of skin tissues for in vitro testing
2002
Adv Drug Deliv Rev 2002 37196;54 Suppl 1):S19-30 | Department of Dermatology, Leiden University Medical Centre, Sylvius Laboratory, Wassenaarseweg 72, 2333 AL Leiden, The Netherlands. [email protected]
Epidermal reconstructs: a new tool to study topical and systemic photoprotective molecules
2002
J Photochem Photobiol B 2002 Nov ;68 (2-3):79-87 | Unite de Dermatologie, Laboratoire de Pathologie Moleculaire et Therapie Genique, INSERM 0217, Universite Victor Segalen, 146 rue Leo Saignat, Batiment TP ouest, 4eme etage, 33076 Bordeaux Cedex, France. [email protected]
Induction of HSP27 nuclear immunoreactivity during stress is modulated by vitamin C
2002
Exp Dermatol 2002 Dec ;11 (6):509-17 | Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.
The use of standardized human skin models for cutaneous pharmacotoxicology studies
2002
Skin Pharmacol Appl Skin Physiol 2002 ;15 Suppl 1):1-3 | L'Oreal, Life Sciences, Advanced Research Laboratories, Clichy, France. [email protected]
Characterization of reconstructed skin models
2002
Skin Pharmacol Appl Skin Physiol 2002 ;15 (Suppl 1):4-17 | Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands. [email protected]
NAD(P)H:quinone reductase activity in human epidermal keratinocytes and reconstructed epidermal models
2002
Skin Pharmacol Appl Skin Physiol 2002 ;15 Suppl 1):68-73 | Paul Gerson Unna-Skin Research Center, Beiersdorf AG, Hamburg, Germany.
Improvement of the experimental setup to assess cutaneous bioavailability on human skin models: dynamic protocol
2002
Skin Pharmacol Appl Skin Physiol 2002 ;15 Suppl 1():31-39 | L'Oreal Research, Aulnay-sous-Bois, France. [email protected]
ECVAM's research and validation activities in the fields of topical toxicity and human studies
2002
Altern Lab Anim 2002 Dec ;30 Suppl 2):119-23 | ECVAM, Institute for Health & Consumer Protection, European Commission Joint Research Centre, 21020 Ispra (VA), Italy.
The contributions of the European cosmetics industry to the development of alternatives to animal testing: dialogue with ECVAM and future challenges
2002
Altern Lab Anim 2002 Dec ;30 Suppl 2):189-93 | L'Oreal, 90 rue de General Roguet, 92583 Clichy Cedex, France.
The seventh amendment to the cosmetics directive: what does DG enterprise want from ECVAM?
2002
Altern Lab Anim 2002 Dec ;30 Suppl 2):213-4 | Enterprise Directorate General, European Commission, 1049 Bruxelles, Belgium.